| Titre : | Substance Use and Misuse, Vol.46, n°2-3 - 2011 - The New York HIV-drug use epidemic : Lessons learned and unresolved issues |
| Type de document : | Bulletin : Périodique |
| Paru le : | 01/04/2011 |
| Année de publication : | 2011 |
| Format : | 129-350 |
| Langues: | Anglais |
| Discipline : | MAL (Maladies infectieuses / Infectious diseases) |
| Mots-clés : |
Thésaurus géographique ETATS-UNISThésaurus mots-clés VIH ; USAGER ; INFECTION ; REDUCTION DES RISQUES ET DES DOMMAGES ; PREVENTION DE PROXIMITE ; PREVENTION |
| Note de contenu : |
CONTENTS:
• Introduction: The New York HIV-drug use epidemic: lessons learned and unresolved issues. Deren S., Hagan H., p. 129-130. • HIV among drug users at Beth Israel Medical Center, New York City, the first 25 years. Des Jarlais D.C., Arasteh K., Friedman S.R., p. 131-139. • Access to sterile syringes for injecting drug users in New York City: politics and perception (1984-2010). Heller D., Paone D., p. 140-149. • The transformation of drug markets and its impact on HIV outreach to injection drug users in New York City, 1987-2008. Furst R.T., Curtis R., Balletto R., p. 150-158. • HIV in the epicenter of the epicenter: HIV and drug use among criminal justice populations in New York City, 1980-2007. Freudenberg N., p. 159-170. • Addressing the HIV-related needs of substance misusers in New York State: the benefits and barriers to implementing a "one-stop shopping" model. Strauss S.M., Mino M., p. 171-180. • Comparison of HIV risk by duration of injection drug use. Vlahov D., Ompad D.C., Fuller C.M., Nandi V., p. 181-191. • Continuing HIV risk in New York City injection drug users: the association of syringe source and syringe sharing. Jenness S.M., Hagan H., Liu K.L., Wendel T., Murrill C.S., p. 192-200. • Sexual risk and HIV infection among drug users in New York City: a pilot study. Hagan H., Perlman D.C., Des Jarlais D.C., p. 201-207. • HIV heterosexual sexual risk from injecting drug users among HIV-seronegative noninjecting heroin users. Neaigus A., Miller M., Gyarmathy V.A., Friedman S.R., p. 208-217. • Strategies to improve access to and utilization of health care services and adherence to antiretroviral therapy among HIV-infected drug users. Cunningham C.O., Sohler N.L., Cooperman N.A., Berg K.M., Litwin A.H., Arnsten J.H., p. 218-232. • Trends related to aging and co-occurring disorders in HIV-infected drug users. Klein R.S., p. 233-244. • Excess mortality among injection drug users with AIDS, New York City (1999-2004). Pfeiffer M.R., Hanna D.B., Begier E.M., Sepkowitz K.A., Zimmerman R., Sackoff J.E., p. 245-253. • HIV risk and prevention among Hispanic immigrants in New York: the salience of diversity. Deren S., Shedlin M., Kang S.Y., Cortes D.E., p. 254-263. • Substance use in the MSM population of New York City during the era of HIV/AIDS. Halkitis P.N., Pollock J.A., Pappas M.K., Dayton A., Moeller R.W., Siconolfi D., et al., p. 264-273. • HIV risk behaviors among young drug using women who have sex with women (WSWs) in New York City. Ompad D.C., Friedman S.R., Hwahng S.J., Nandi V., Fuller C.M., Vlahov D., p. 274-284. • Overview of HIV among injection drug users in New York City: critical next steps to eliminate racial/ethnic disparities. Amesty S., Rivera A.V., Fuller C.M., p. 285-294. • Intimate partner violence and HIV among drug-involved women: contexts linking these two epidemics--challenges and implications for prevention and treatment. El-Bassel N., Gilbert L., Witte S., Wu E.W., Chang M.W., p. 295-306. • Symbiotic goals and the prevention of blood-borne viruses among injection drug users. Friedman S.R., Sandoval M., Mateu-Gelabert P., Meylakhs P., Des Jarlais D.C., p. 307-315. • Current and emerging research needs in studying the NYC HIV-drug use epidemic. Deren S., Hagan H., Friedman S., Des Jarlais D.C., Perlman D., Gwadz M., et al., p. 316-319. |
| Domaine : | Drogues illicites / Illicit drugs |
| Lien : | http://www.tandfonline.com/toc/isum20/46/2-3 |
Dépouillements
Ajouter le résultat dans votre panierArticle : Périodique
In the United States, political and social environments have shaped public health response to injecting drug use, and New York City represents a salient example. The history of "harm reduction" in New York City is characterized within changing h[...]
Article : Périodique
D. VLAHOV ;
D. C. OMPAD ;
C. M. FULLER ;
V. NANDI
|
Early studies documented an inverse association between the HIV risk and duration of injection among injection drug users (IDUs). Results from subsequent studies have been inconsistent. To examine this issue, we conducted interviews with 395 str[...]
Article : Périodique
S. M. JENNESS ;
H. HAGAN ;
K. L. LIU ;
T. WENDEL ;
C. S. MURRILL
|
Sterile syringe access is an important means to reduce HIV risk, but many injection drug users (IDU) who obtain syringes from sterile sources continue to share syringes. We examined the factors associated with continuing syringe sharing in New Y[...]
Article : Périodique
We calculated proportions and trends in contributing causes of death among persons with AIDS (PWA) and a history of injection drug use (IDU) in New York City and compared the proportions with those among PWA with a transmission risk of high-risk[...]
Article : Périodique
S. DEREN ;
H. HAGAN ;
S. FRIEDMAN ;
D. C. DES JARLAIS ;
D. PERLMAN ;
M. GWADZ ;
C. CLELAND ;
A. OSBORNE ;
J. LUNIEVICZ
|
As we begin the fourth decade of the epidemic, it is clear that, as demonstrated by the articles in this Special Issue, much has been learned about factors contributing to the decline in HIV prevalence among drug users in New York. However, ther[...]
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |
Accueil
